Inventor

George C. Y. Chiou

Inventor
College Station, TX, US

Overview

23→
Patents
1984–2021
Patent span
Human necessities
Primary field (CPC A)

Patents· 23 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary
A61KPreparations for medical, dental or toiletry purposes68%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations14%
A43BCharacteristic features of footwear7%
B60RVehicles, vehicle fittings, or vehicle parts, not otherwise provided for4%
C07DHeterocyclic compounds4%
Y10STechnical subjects covered by former uspc cross-reference art collections [xracs] and digests4%
PatentTitleYear
11,045,435Methods for treating ocular diseases202110,448,700Shoe having multiple sole members20199,999,274Shoe having multiple sole members20188,318,741'Therapeutic compositions and methods'20128,088,773'Therapeutic compositions and methods'20126,422,443'Bicycle carrier with unitary frame and leveling indicators'20025,364,884'Arginine compounds as ocular hypotensive agents'19945,344,829'Use of OB-101 to treat inflammation'19945,283,236'Systemic delivery of polypeptides through the eye'19945,278,142'Systemic delivery of polypeptides through the eye'19945,266,580'Treatment of low pressure glaucoma and ischemic retinal degeneration with droperidol'19935,252,568'Treatment of low pressure glaucoma and ischemic retinal degeneration with loxapine'19935,252,607'Treatment of low pressure glaucoma and ischemic retinal degeneration'19935,240,936'Treating or preventing ocular inflammation or systemic imflammatory disease'19935,198,454'Use of OB-104 to treat ocular inflammation'19935,194,434'Use of OB-101 to treat ocular inflammation'19935,182,258'Systemic delivery of polypeptides through the eye'19935,041,450'Treatment of ocular inflammation'19914,865,599'Ophthalmic compositions for treating nerve degeneration'19894,772,616'Treatment of ocular hypertension and glaucoma with dopamine antagonists'19884,565,821'Method and ophthalmic composition for treating ocular hypertension and glaucoma with butyrophenones'19864,521,414'Ophthalmic compositions and their use for treating elevated intraocular pressure and glaucoma'19854,459,309'Compositions and methods of lowering intraocular pressure in the hypertensive mammalian eye'1984

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1984–2012Patents assigned to TEXAS A & M UNIV SYS (14)· patent assignee history
1984–2012Based in College Station, TX, US· patent location history
1993–1994Patents assigned to ORBON CORP (3)· patent assignee history
1994Patents assigned to BAYLOR COLLEGE MEDICINE (1)· patent assignee history
2002Based in Oakland, CA, US· patent location history
2012Patents assigned to CHIOU GEORGE C (2)· patent assignee history
2018–2019Patents assigned to COLE HAAN LLC (2)· patent assignee history
2018–2019Based in Beaverton, OR, US· patent location history
2021Based in Taipei, TW· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
TEXAS A & M UNIV SYS141984–2012
ORBON CORP31993–1994
CHIOU GEORGE Cself22012
COLE HAAN LLC22018–2019
BAYLOR COLLEGE MEDICINE11994
Locations
LocationPatentsSpan
College Station, Texas, US191984–2012
Beaverton, OR, US22018–2019
Taipei, TW12021
Oakland, California, US12002